Scinovex
articleTop 10% cited

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

European Journal of Cancer · 2005 · Vol. 42(1) · pp. 50–54
Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrologic and reproductive health conditionsMedicineRegimenHazard ratioSurgeryChemotherapyUrologyGastroenterologyInternal medicineConfidence interval

MeSH terms

AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Transitional CellCisplatinDoxorubicinFemaleFollow-Up StudiesHumansMaleMethotrexateMiddle AgedUrologic NeoplasmsVinblastine
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.